The risk of early, sudden-onset menopause in women treated for early-stage breast cancer can be reduced with goserelin, a gonadotropin-releasing hormone agonist.
New evidence reveals that risk prediction for breast cancer is imperative in women with atypical hyperplasia of breast tissue.
Despite having advantages over conventional whole breast irradiation, hypofractionated WBI is used by only a third of patients who would benefit.
Evidence is mounting that digital tomosynthesis has better cancer detection rates than digital mammography, especially for women with dense breasts.
A new (theoretical) model using multiple data points, including genetic testing for BRCA genes, could identify women at greatest risk for breast cancer.
Breast cancer awareness campaigns are great, but they should be expanded to provide more clinician education on health disparities and to target women most at risk.
Physicians can help older women make informed mammography decisions by taking into account life expectancy and the harms and benefits of breast cancer screening.
Hot flashes and other vasomotor symptoms in postmenopausal women with breast cancer taking aromatase inhibitors were significantly improved after acupuncture, study finds.
The publicity surrounding Angelina Jolie's preventive mastectomy was a missed opportunity to educate the public about the true risks of BRCA gene mutation.
Human breast tissue tests link reduced amounts of mitochondrial DNA content with a greater incidence of metastatic breast cancer.